Joan B. Rebassa

Barcelona, CT 08035, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential.

The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential.

Journal: Brain sciences
Published: September 05, 2025

Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Journal: Journal of medicinal chemistry
Published: August 12, 2025

The Interplay Between CB2 and NMDA Receptors in Parkinson's Disease.

The Interplay Between CB2 and NMDA Receptors in Parkinson's Disease.

Journal: International journal of molecular sciences
Published: August 08, 2025

Metadynamics simulations and site-directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptor.

Metadynamics simulations and site-directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptor.

Journal: Protein science : a publication of the Protein Society
Published: June 04, 2025

Cannabidiol releases CB1R from A2AR repression in ischemic stroke.

Cannabidiol releases CB1R from A2AR repression in ischemic stroke.

Journal: Neurobiology of disease
Published: April 07, 2025

Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.

Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.

Journal: ACS pharmacology & translational science
Published: March 31, 2025

Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function.

Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function.

Journal: Alzheimer's research & therapy
Published: February 17, 2025

Future Perspectives of NMDAR in CNS Disorders.

Future Perspectives of NMDAR in CNS Disorders.

Journal: Molecules (Basel, Switzerland)
Published: January 14, 2025

Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.

Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.

Journal: Pharmacological research
Published: May 11, 2024

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease.

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease.

Journal: International journal of molecular sciences
Published: April 11, 2024

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke.

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke.

Journal: International journal of molecular sciences
Published: April 03, 2024

Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease.

Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease.

Journal: International journal of molecular sciences
Published: February 27, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026